Mandate

Vinge advises Industrifonden in connection with Actiwave investment

August 31, 2012

Vinge has advised Industrifonden in connection with its SEK 13 million investment in Actiwave, a company which has developed a new form of digital audio technology which improves the sound quality in, among other things, mobile phones and tablet computers. The current owner, SEB Venture Capital, is also participating in the investment.

Industrifonden invests in small and medium-sized Swedish companies with international growth potential. Industrifonden has assets of SEK 3.8 billion and has invested in 89 companies within the technology, cleantech, life science and industrial sectors.

Vinge’s team consisted of partner Johan Larsson together with associates Karl Svantemark, Evelina Tejle and Karl Hahtovirta.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026